Pain and Inflammation Research
Although separate conditions, pain and inflammation are nearly always associated with each other. Pain is defined by the International Association for the Study of Pain (IASP) as 'an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage'. Inflammation is the tissue's immunologic response to injury, characterized by mobilization of white blood cells and antibodies, swelling, and fluid accumulation.
Pain and Inflammation Research Products Areas
Products for Pain and Inflammation Research - Page 98
- Cat.No. Product Name Information/Activity
-
BCC5707
L-733,060 hydrochloride
148687-76-7
-
BCC7134
RP 67580
135911-02-3
-
BCC7349
SDZ NKT 343
180046-99-5
-
BCC5808
Spantide I
91224-37-2
-
BCC6098
SR 140333
153050-21-6
-
BCC5800
GR 64349
137593-52-3
-
BCC7137
[bAla8]-Neurokinin A(4-10)
[bAla8]-Neurokinin A(4-10) is a neurokinin 2 (NK2) receptor agonist.
-
BCC5994
[Lys5,MeLeu9,Nle10]-NKA(4-10)
137565-28-7
-
BCC7001
GR 159897
GR 159897 is a highly potent, selective, competitive, brain-penetrated non-peptide neurokinin 2 (NK2) receptor antagonist. GR 159897 has little or no affinity for NK1 and NK3 receptors. GR 159897 inhibits binding of [3H]GR100679 to human NK2 (hNK2)-CHO cells and rat colon membranes with pKis of 9.51 and 10, respectively. Antagonizes bronchoconstriction. Anxiolytic-like and anti-tumor effects.
-
BCC5799
GR 94800
141636-65-9


